IBM International Business Machines Corp.
International Business Machines Corp. is an information technology company, which provides integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Cognitive Solutions, Global Business Services, Technology Services & Cloud Platforms, Systems, and Global Financing. The Cognitive Solutions segment comprises a portfolio of capabilities that help IBM's clients to identify actionable insights and inform decision making for competitive advantage. It includes Watson, a cognitive computing platform that has the ability to interact in natural language, process amounts of big data, and learn from interactions with people and computers. This segment consists of Solutions Software, which provides the basis for many of the company's strategic areas including analytics, security and social; and Transaction Processing Software, which includes software that primarily runs mission-critical systems in industries such as banking, airlines and retail. The Global Business Services segment provides clients with consulting, application management and global process services. The Technology Services & Cloud Platforms segment provides comprehensive IT infrastructure and platform services that create business value for clients. The Systems segment provides clients with innovative infrastructure platforms to help meet the requirements of hybrid cloud and enterprise AI workload. The Global Financing segment encompasses two primary businesses: financing, primarily conducted through IBM Credit LLC, and remanufacturing and remarketing. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.
Company profile
Ticker
IBM
Exchange
Website
CEO
Virginia M. Rometty
Employees
Incorporated in
Location
Fiscal year end
Industry (SEC)
SEC CIK
Corporate docs
IRS number
130871985
Calendar
30 Oct 19
25 Feb 20
31 Dec 20
News
Company financial data Financial data
| Quarter (USD) | Sep 19 | Jun 19 | Mar 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | 18.03B | 19.16B | 18.18B | 21.76B | |
| Net income | 1.67B | 2.5B | 1.59B | 1.95B | |
| Diluted EPS | 1.87 | 2.81 | 1.78 | 2.15 | |
| Net profit margin | 9.27% | 13.04% | 8.75% | 8.97% | |
| Operating income* | 1.95B | 3.12B | 2.09B | 4.63B | |
| Net change in cash | -35.31B | 28.27B | 5.76B | -184M | |
| Cash on hand | 10.09B | 45.4B | 17.13B | 11.38B | |
| Cost of revenue | 9.69B | 10.15B | 10.14B | 11.07B |
| Annual (USD) | Dec 18 | Dec 17 | Dec 16 | Dec 15 | |
|---|---|---|---|---|---|
| Revenue | 79.59B | 79.14B | 79.92B | 81.74B | |
| Net income | 8.73B | 5.75B | 11.87B | 13.19B | |
| Diluted EPS | 9.52 | 6.14 | 12.38 | 13.42 | |
| Net profit margin | 10.97% | 7.27% | 14.86% | 16.14% | |
| Operating income* | 12.07B | 12.02B | 12.96B | 16.41B | |
| Net change in cash | -593M | 4.15B | 140M | -790M | |
| Cash on hand | 11.38B | 11.97B | 7.83B | 7.69B | |
| Cost of revenue | 42.66B | 42.2B | 41.4B | 41.06B |
Financial data from company earnings reports. *Asterisk values are approximate.
Institutional ownership Q4 2019
56.2% owned by funds/institutions
13F holders |
Current |
|---|---|
| Total holders | 1998 |
| Opened positions | 224 |
| Closed positions | 149 |
| Increased positions | 704 |
| Reduced positions | 819 |
13F shares |
Current |
|---|---|
| Total value | 801.02B |
| Total shares | 497.29M |
| Total puts | 12.74M |
| Total calls | 8.89M |
| Total put/call ratio | 1.4 |
Largest owners |
Shares | Value |
|---|---|---|
| Vanguard | 73.44M | $9.84B |
| BLK BlackRock | 62.13M | $8.33B |
| STT State Street | 54.49M | $7.3B |
| Geode Capital Management | 12.84M | $1.72B |
| NTRS Northern Trust | 11.05M | $1.48B |
| BK Bank Of New York Mellon | 10.09M | $1.35B |
| MS Morgan Stanley | 9.76M | $1.31B |
| BAC Bank of America | 7.63M | $1.02B |
| Charles Schwab Investment Management | 7.58M | $1.02B |
| AMP Ameriprise Financial | 6.43M | $862.53M |
Financial report summary
?Competition
Intel • Leidos • CA • LSI • Quantum • Sun Microsystems • Oracle • Qualstar • Oracle Systems • MicrosoftManagement Discussion
- In the third quarter, Global Financing total revenue of $645 million declined 11.2 percent compared to the prior year. Internal revenue decreased 10.6 percent, driven by a decrease in internal financing (down 21.7 percent to $86 million) and internal used equipment sales (down 5.2 percent to $216 million). External revenue decreased 11.7 percent (11 percent adjusted for currency), due to a decrease in external financing (down 14.6 percent to $261 million) and external used equipment sales (down 1.0 percent to $81 million).
- The decrease in total revenue in the first nine months of 2019 compared to the same period of 2018 was due to a decrease in internal revenue of 28.7 percent, driven by a decrease in internal used equipment sales (down 36.0 percent to $593 million) and internal financing (down 7.4 percent to $291 million). External revenue decreased 7.4 percent (5 percent adjusted for currency), driven by a decline in external used equipment sales (down 19.9 percent to $216 million) and external financing (down 3.7 percent to $884 million).
- The decrease in internal financing revenue in the third quarter and the first nine months of 2019 compared to the same periods in 2018 was primarily due to lower average asset balances, partially offset by higher asset yields. The decrease in external financing revenue in the third quarter and the first nine months of 2019 compared to the same periods in 2018 reflects the company’s wind down of the OEM IT commercial financing operations.
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
acquiree, advisory, amortizable, Ansible, assembled, attrition, back, CIS, CISGIL, consumed, consummated, containerizing, cyber, deal, deductible, earned, equivalent, facing, fiscal, forma, holistic, instant, Internet, introduction, larger, leading, lifecycle, McNabb, NaN, native, OpenShift, pro, purport, resource, retention, RHEL, Salesforce, settle, settled, slightly, temporary, thirteen, weaker, week, William, wrongful
Financial reports
10-Q
2019 Q3
Quarterly report
30 Oct 19
10-Q
2019 Q2
Quarterly report
30 Jul 19
10-Q
2019 Q1
Quarterly report
30 Apr 19
10-K
2018 FY
Annual report
26 Feb 19
10-Q
2018 Q3
Quarterly report
30 Oct 18
10-Q
2018 Q2
Quarterly report
31 Jul 18
10-Q
2018 Q1
Quarterly report
24 Apr 18
10-K
2017 FY
Annual report
27 Feb 18
10-Q
2017 Q3
Quarterly report
31 Oct 17
10-Q
2017 Q2
Quarterly report
25 Jul 17
Current reports
8-K
Financial Statements and Exhibits
10 Feb 20
8-K
Other Events
3 Feb 20
8-K
Arvind Krishna Elected Ibm Chief Executive Officer
31 Jan 20
8-K
Departure of Directors or Certain Officers
29 Jan 20
8-K
Regulation FD Disclosure
22 Jan 20
8-K
Ibm Reports 2019 Fourth-quarter and Full-year Results
21 Jan 20
8-K
Other Events
22 Nov 19
8-K
Ibm Elects Thomas Buberl to Its Board of Directors
12 Nov 19
8-K
Regulation FD Disclosure
17 Oct 19
8-K
Ibm Reports 2019 Third-quarter Results
16 Oct 19
Registration and prospectus
8-A12B
Registration of securities on exchange
10 Feb 20
424B5
Prospectus supplement for primary offering
6 Feb 20
FWP
Free writing prospectus
4 Feb 20
424B3
Prospectus supplement
4 Feb 20
25-NSE
Exchange delisting
19 Nov 19
25-NSE
Exchange delisting
1 Nov 19
S-8
Registration of securities for employees
9 Jul 19
424B5
Prospectus supplement for primary offering
10 May 19
FWP
Free writing prospectus
9 May 19
424B3
Prospectus supplement
8 May 19
Proxies
DEFA14A
Additional proxy soliciting materials
3 Apr 19
DEFA14A
Additional proxy soliciting materials
25 Mar 19
DEF 14A
Definitive proxy
11 Mar 19
DEFA14A
Additional proxy soliciting materials
2 Apr 18
DEF 14A
Definitive proxy
12 Mar 18
DEFA14A
Additional proxy soliciting materials
5 Apr 17
PX14A6G
Letter to shareholders
27 Mar 17
DEF 14A
Definitive proxy
13 Mar 17
DEFA14A
Additional proxy soliciting materials
1 Apr 16
DEF 14A
Definitive proxy
7 Mar 16
Other
SD
Conflict minerals disclosure
31 May 19
SD
Conflict minerals disclosure
25 May 18
SD
Conflict minerals disclosure
26 May 17
CERTNYS
Certification of approval for NYSE listing
23 May 17
NO ACT
No action letter
6 Jan 17
NO ACT
No action letter
9 Dec 16
NO ACT
No action letter
16 Nov 16
CERTNYS
Certification of approval for NYSE listing
2 Nov 16
UPLOAD
Letter from SEC
8 Jul 16
CORRESP
Correspondence with SEC
6 Jul 16
Ownership
SC 13G
International Business Machines Corp
13 Feb 20
SC 13G/A
Beneficial ownership report (amended)
12 Feb 20
SC 13G/A
International Business Machines Corp
5 Feb 20
SC 13G
International Business Machines Corp
13 Feb 19
SC 13G/A
International Business Machines Corp
13 Feb 19
SC 13G/A
International Business Machines Corp
4 Feb 19
SC 13G
International Business Machines Corp
14 Feb 18
SC 13G
International Business Machines Corp
14 Feb 18
SC 13G/A
International Business Machines Corp
14 Feb 18
SC 13G/A
International Business Machines Corp
9 Feb 18
Patents
GRANT
Utility
Surgical skin lesion removal
25 Feb 20
Embodiments include methods, systems, and computer program products for treating skin lesions.
GRANT
Utility
Apparatus for supporting personalized coronary stents
25 Feb 20
A method including generating a 3-D model of an unstenosed geometry of a blood vessel responsive to a 3-D model of an actual geometry of the blood vessel, establishing a parametric description of a stent that is expanded from a collapsed configuration to a final configuration that apposes the unstenosed geometry, developing a design for the stent by varying parameters of the parametric description responsive to a design heuristic that includes risk of stent strut breakage during a plastic deformation between the collapsed configuration and the final configuration, embodying the stent according to the design for the stent, inserting the stent into a blood vessel in its collapsed configuration, maneuvering the stent through the blood vessel to a stenosis, and expanding the stent to its final configuration.
GRANT
Utility
Personalized coronary stent methods
25 Feb 20
A method including generating a 3-D model of an unstenosed geometry of a blood vessel responsive to a 3-D model of an actual geometry of the blood vessel, establishing a parametric description of a stent that is expanded from a collapsed configuration to a final configuration that apposes the unstenosed geometry, developing a design for the stent by varying parameters of the parametric description responsive to a design heuristic that includes risk of stent strut breakage during a plastic deformation between the collapsed configuration and the final configuration, embodying the stent according to the design for the stent, inserting the stent into a blood vessel in its collapsed configuration, maneuvering the stent through the blood vessel to a stenosis, and expanding the stent to its final configuration.
GRANT
Utility
Drying an extreme ultraviolet (EUV) pellicle
25 Feb 20
Systems and methods for rinsing one or more pellicles during fabrication, including immersing and soaking the one or more pellicles in a rinse bath solution for a particular time period, forming a top layer above the rinse bath solution, the top layer having a lower surface tension than the rinse bath, and withdrawing the one or more pellicles through the top layer for drying.
GRANT
Utility
Maintenance of a machine
25 Feb 20
A system for maintaining a machine.